Showing results (541-550 of 753) with videos related to
Sort By:
Pageof 76
Neuro-Oncology|October 10, 2015
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II studyNicholas Butowski, Howard Colman, John F De Groot, et al.The Lancet. Oncology|June 6, 2020
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working groupCraig Erker, Benita Tamrazi, Tina Y Poussaint, et al.Neuro-Oncology Advances|August 9, 2023
Evaluating hematologic parameters in newly diagnosed and recurrent glioblastoma: Prognostic utility and clinical trial implications of myelosuppressionDavy Deng, Lubna Hammoudeh, Gilbert Youssef, et al.Biorxiv : the Preprint Server for Biology|April 2, 2024
A comprehensive analysis of Transcribed Ultra Conserved Regions uncovers important regulatory functions of novel non-coding transcripts in gliomasMyron K Gibert, Ying Zhang, Shekhar Saha, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 6, 2018
Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiationDaniel N Cagney, Allison M Martin, Paul J Catalano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium studyJohn F de Groot, Kathleen R Lamborn, Susan M Chang, et al.Neuro-Oncology|February 5, 2019
The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposalEmilie Le Rhun, Patrick Devos, Thomas Boulanger, et al.Journal of Neuro-Oncology|January 25, 2017
Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomasLakshmi Nayak, John de Groot, Jeffrey S Wefel, et al.Neuro-Oncology|December 18, 2019
Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II studyAndrew J Brenner, Katherine B Peters, James Vredenburgh, et al.The Lancet. Oncology|February 3, 2022
Therapeutic avenues for cancer neuroscience: translational frontiers and clinical opportunitiesDiana D Shi, Jimmy A Guo, Hannah I Hoffman, et al.Pageof 76